Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant

• Status: Terminated
• Trial end date: 2006-04-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a multi-center, randomized, double-masked, controlled study to evaluate the safety and efficacy of fluocinolone acetonide intravitreal implants for the management of subjects with non-infectious uveitis affecting the posterior segment of the eye. An additional objective is to compare the safety and efficacy of two doses of fluocinolone acetonide.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bausch & Lomb Incorporated
• Treatments: Fluocinolone Acetonide

Criteria

Inclusion Criteria:

• Males or non-pregnant females at least 6 years of age who had been diagnosed and treated for recurrent,

• Non-infectious uveitis affecting the posterior segment of one or both eyes for at least 1 year prior to the start of the study,

• Had clinically 'quiet' eyes at surgery.

Exclusion Criteria:

• Coexistent medical or ocular conditions that would interfere with obtaining or interpreting data for this study.